|
| |
Image Results
Loading...
Loading...
Acorn Cardiovascular Clinical Trial Results Pages on BioPortfolio:
|
BioPortfolio - Methods
... promoter polymorphisms: implications for investigations of cardiovascular disease. ... Air Methods to Report Third Quarter Financial Results After Market
Close on Thursday, ... Methods Clinical Trials: Clinical Trials Logo ... Acorn
NMR operates an NMR spectroscopy service with its modified NT 300 and 360 NMR
...
http://www.bioportfolio.com/indepth/Methods.html...
|
BioPortfolio - ChemoCentryx, Inc.
Our pipeline includes: Traficet-EN™ currently in Phase II clinical ... targeting the receptor CCR2, into clinical trials this year. ... PROTECT-1 Phase II/III
Induction-Stage Results for ChemoCentryx's ... Weekly CEO Buys Highlight: DSW
Inc, Sunstone Hotel Investors Inc, Progenics Pharmaceuticals Inc, Acorn Energy
...
http://www.bioportfolio.com/biocorporate/20818-ChemoCentryx,...
|
BioPortfolio - ChemoCentryx, Inc. - Profile
program, ChemoCentryx intends to take a new drug candidate for multiple sclerosis and cardiovascular disease, targeting the receptor CCR2, into clinical
trials this year. Also, two promising compounds targeting ... BioNews Results
for ChemoCentryx, Inc. ... Acorn Energy. Guru Focus: Oct 24 2009 9:49PM Matching
: inc ...
http://www.bioportfolio.com/biocorporate/20818-ChemoCentryx,...
|
BioPortfolio - Kos Pharmaceuticals, Inc - Profile
... prescription pharmaceutical products, principally for treatment of cardiovascular, ... financial results in a press release to be issued after 8:00
... Acorn Energy. Guru Focus: Oct 24 2009 9:49PM Matching: pharmaceuticals inc
... information resources: publications, clinical trials, patents and global
news. ...
http://www.bioportfolio.com/biocorporate/25376-Kos%2BPharmac...
|
BioPortfolio - Prolexys Pharmaceuticals, Inc. - Profile
The Company's therapeutic focus is on cancer and cardiovascular indications where Prolexys has ... BioNews Results for Prolexys Pharmaceuticals, Inc. ...
Acorn Energy. Guru Focus: Oct 24 2009 9:49PM Matching: pharmaceuticals inc ...
information resources: publications, clinical trials, patents and global news.
...
http://www.bioportfolio.com/biocorporate/28691-Prolexys+Phar...
|
BioPortfolio - PE Corporation - Profile
Year 2010 Results. 29th October, 2009 Repligen Corporation. WALTHAM, Mass., Oct. 29. /PRNewswire-FirstCall/ -- ... Acorn Energy. Guru Focus: Oct 24 2009 9:49PM
Matching: pe ... Cardiovascular Business: Oct 23 2009 2:25AM Matching: pe ...
information resources: publications, clinical trials, patents and global news.
...
http://www.bioportfolio.com/biocorporate/8126-PE%252BCorpora...
|
BioPortfolio - Intercure, Inc.
... for respiratory-based treatment of cardiovascular and pulmonary diseases. ... InterCure heart failure product, InTone™; has successfully completed phase
2a efficacy clinical trials and is ... Hotel Investors Inc, Progenics
Pharmaceuticals Inc, Acorn Energy ... BioPortfolio search results for Intercure,
Inc. ...
http://www.bioportfolio.com/biocorporate/24740-Intercure,_In...
| Results from other life science and pharmaceutical sites:
CONFIDENTIAL CorCap Cardiac Support Device (CSD) (P040049) Acorn ...
CLINICAL STUDY RESULTS. • The pivotal clinical trial of the CorCap CSD met all protocol-specified .... Assurance, Acorn Cardiovascular, Inc. June 1, 2006. ...
http://www.fda.gov/ohrms/dockets/AC/06/briefing/2006-4269b1_...
|
Mitral valve surgery in heart failure: insights from the Acorn ...
... with and without the CorCap cardiac support device (Acorn Cardiovascular, ... the mitral valve repair or replacement stratum of the Acorn Clinical Trial;
... RESULTS: For the entire mitral valve surgery group, the 30-day operative ...
http://www.ncbi.nlm.nih.gov/pubmed/16935112...
|
CorCap Cardiac Support Device (CSD) (P040049) Acorn Cardiovascular ...
Acorn maintains that another clinical trial is not needed ... Acorn claims that they were able to clinically validate the results of their focused cohort ...
http://www.fda.gov/ohrms/DOCKETS/ac/06/briefing/2006-4269b1_...
|
News: Acorn Cardiovascular to Conduct 50-Patient Confirmatory ...
9 May 2007 ... Acorn Cardiovascular announced today that the Food and Drug Administration ... Following a six-month follow-up period and pending positive results, ... pivotal
trial and is designed to address the specific clinical data ...
http://www.genengnews.com/news/bnitem.aspx?name=17144661...
|
The Acorn Cardiovascular Cardiac Support Device (CSD) Clinical Trial
NYHA Class I: There is clinical evidence of heart failure or some other ... Acorn Cardiovascular. Why might a physician consider treatment with the CorCap
...
http://www.fda.gov/ohrms/DOCKETS/ac/05/briefing/2005-4149b1_...
|
Sustained benefits of the CorCap Cardiac Support Device on left ...
... remodeling: three year follow-up results from the Acorn clinical trial. ... the CorCap Cardiac Support Device (CSD; Acorn Cardiovascular, Inc, St. Paul, ...
http://www.ncbi.nlm.nih.gov/pubmed/17888975...
|
The Acorn Cardiovascular Cardiac Support Device (CSD) Clinical Trial
NYHA Class I: There is clinical evidence of heart failure or some other cardiac disease, but the patient's physician activity is not limited by symptoms. ...
http://www.fda.gov/ohrms/DOCKETS/ac/05/briefing/2005-4149b1_...
|
Neurohormonal and echocardiographic results after CorCap and ...
... CorCap Cardiac Support Device (Acorn Cardiovascular Inc, St. Paul, MN) and RMA. Clinical, echocardiographic, New York Heart Association (NYHA) ... BNP at
short-term follow-up together with slightly improved echocardiographic and
functional results. ... Comparative Study; Randomized Controlled Trial. Mesh
Terms: ...
http://www.ncbi.nlm.nih.gov/pubmed/19699885...
|
Medical Devices Dispute Resolution Meeting
Cardiovascular, Inc. (Acorn), is a non-resorbable polyester mesh ... Specifically, Acorn believes the 300 patient clinical trial provides valid
scientific ... Whether the overall trial results for the primary effectiveness
endpoint are ...
http://www.fda.gov/ohrms/DOCKETS/ac/06/questions/2006-4269q1...
|
Clinical evaluation of the CorCap Cardiac Support Device in ...
The CorCap Cardiac Support Device (CSD; Acorn Cardiovascular, Inc, St. Paul, ... CONCLUSIONS: The results of the Acorn trial support the hypothesis that ...
http://www.ncbi.nlm.nih.gov/pubmed/17888974...
|
|
